A progressive and complex clinical course in two family members with ERF-related craniosynostosis: a case report.


Journal

BMC medical genetics
ISSN: 1471-2350
Titre abrégé: BMC Med Genet
Pays: England
ID NLM: 100968552

Informations de publication

Date de publication:
05 05 2020
Historique:
received: 18 09 2019
accepted: 29 03 2020
entrez: 7 5 2020
pubmed: 7 5 2020
medline: 17 7 2020
Statut: epublish

Résumé

ERF-related craniosynostosis are a rare, complex, premature trisutural fusion associated with a broad spectrum of clinical features and heterogeneous aetiology. Here we describe two cases with the same pathogenic variant and a detailed description of their clinical course. Two subjects; a boy with a BLSS requiring repeated skull expansions and his mother who had been operated once for sagittal synostosis. Both developed intracranial hypertension at some point during the course, which was for both verified by formal invasive intracranial pressure monitoring. Exome sequencing revealed a pathogenic truncating frame shift variant in the ERF gene. Here we describe a boy and his mother with different craniosynostosis patterns, but both with verified intracranial hypertension and heterozygosity for a truncating variant of ERF c.1201_1202delAA (p.Lys401Glufs*10). Our work provides supplementary evidence in support of previous phenotypic descriptions of ERF-related craniosynostosis, particularly late presentation, an evolving synostotic pattern and variable expressivity even among affected family members.

Sections du résumé

BACKGROUND
ERF-related craniosynostosis are a rare, complex, premature trisutural fusion associated with a broad spectrum of clinical features and heterogeneous aetiology. Here we describe two cases with the same pathogenic variant and a detailed description of their clinical course.
CASE PRESENTATION
Two subjects; a boy with a BLSS requiring repeated skull expansions and his mother who had been operated once for sagittal synostosis. Both developed intracranial hypertension at some point during the course, which was for both verified by formal invasive intracranial pressure monitoring. Exome sequencing revealed a pathogenic truncating frame shift variant in the ERF gene.
CONCLUSIONS
Here we describe a boy and his mother with different craniosynostosis patterns, but both with verified intracranial hypertension and heterozygosity for a truncating variant of ERF c.1201_1202delAA (p.Lys401Glufs*10). Our work provides supplementary evidence in support of previous phenotypic descriptions of ERF-related craniosynostosis, particularly late presentation, an evolving synostotic pattern and variable expressivity even among affected family members.

Identifiants

pubmed: 32370745
doi: 10.1186/s12881-020-01015-z
pii: 10.1186/s12881-020-01015-z
pmc: PMC7201657
doi:

Substances chimiques

ERF protein, human 0
Repressor Proteins 0

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

90

Références

Plast Reconstr Surg. 2010 Jan;125(1):299-304
pubmed: 20048621
J Med Genet. 2017 Mar;54(3):157-165
pubmed: 27738187
Am J Med Genet A. 2017 May;173(5):1406-1429
pubmed: 28160402
J Med Genet. 2006 Jun;43(6):534-40
pubmed: 16258006
Nat Genet. 2013 Mar;45(3):308-13
pubmed: 23354439
J Craniofac Surg. 1998 Sep;9(5):417-22
pubmed: 9780908
Eur J Pediatr. 1976 Aug 16;123(1):15-28
pubmed: 954768
J Craniofac Surg. 2009 Sep;20 Suppl 2:1843-50
pubmed: 19816363
Am J Med Genet A. 2015 Nov;167A(11):2544-7
pubmed: 26097063
Am J Med Genet A. 2019 Apr;179(4):615-627
pubmed: 30758909
Am J Med Genet A. 2009 May;149A(5):1024-32
pubmed: 19396832
Am J Med Genet A. 2004 Jul 15;128A(2):214-6
pubmed: 15214020
J Craniofac Genet Dev Biol. 2000 Jan-Mar;20(1):19-25
pubmed: 10879654
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Eur J Med Genet. 2019 Jun;62(6):103526
pubmed: 30125677
Childs Nerv Syst. 2013 Jun;29(6):997-1005
pubmed: 23334575

Auteurs

Izabella Körberg (I)

Department of Immunology, Genetics and Pathology, Uppsala University, Science for Life Laboratory, Uppsala, Sweden. izabella.baranowska.korberg@akademiska.se.

Daniel Nowinski (D)

Department of Surgical Sciences, Plastic Surgery, Uppsala University, Uppsala, Sweden.

Marie-Louise Bondeson (ML)

Department of Immunology, Genetics and Pathology, Uppsala University, Science for Life Laboratory, Uppsala, Sweden.

Malin Melin (M)

Department of Immunology, Genetics and Pathology, Uppsala University, Science for Life Laboratory, Uppsala, Sweden.

Lars Kölby (L)

Department of Plastic Surgery, Institute for Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.

Eva-Lena Stattin (EL)

Department of Immunology, Genetics and Pathology, Uppsala University, Science for Life Laboratory, Uppsala, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH